The Platelet Aggregation After tiCagrelor Inhibition and FentanYl Trial (PACIFY)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 212 participants.

Also called NCT02683707

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 212 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02683707
Other papers using this trial's data
  • Fentanyl Delays the Platelet Inhibition Effects of Oral Ticagrelor: Full Report of the PACIFY Randomized Clinical Trial Thrombosis and haemostasis, 2018-08 DOI, PubMed 29972861, PMC6202927 In the PMC Open Access subset under CC BY-NC-ND.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02683707. Randomized; single masking; primary purpose treatment. Start 2016-03 (registry gives no type); primary completion 2017-05-25 (actual). Results posted on 2018-05-09.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Platelet Aggregation After tiCagrelor Inhibition and FentanYl Trial (PACIFY)
Acronym
PACIFY
Intervention (Other)
Removal of Fentanyl from peri-procedural analgesia
Intervention (Drug)
Fentanyl
Intervention (Drug)
Lidocaine
Intervention (Drug)
Midazolam
Lead sponsor
Johns Hopkins University (class: other)

Record details

Record id
cardio:ct-nct02683707
Content hash
803c5a21145be7e42ccbe7e07188848dd5cad82a96c73e5905f6d6902756ceda